# A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand

> **NCT00370682** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 120 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** T-DEN F17
- **BIOLOGICAL:** T-DEN F-19
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT00370682
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370682, "A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00370682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*